Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June
OUH - Cancer Genome Variation
Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction - ScienceDirect
An overview of genetic services delivery for hereditary breast cancer
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus
Gene panel screening for insight towards breast cancer susceptibility in different ethnicities
FDA Authorizes First Genetic Test to Assess Risk of Multiple Cancers
A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk
Cancer Genetics Risk Assessment and Counseling (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer, BMC Medicine
Breast Cancer Susceptibility—Towards Individualised Risk Prediction
Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation - ScienceDirect
Managing breast cancer in younger women: challenges and solutions
Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families - ScienceDirect
Detailed Methods - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA1/2-Related Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force - NCBI Bookshelf
